Christophe Berthoux, MD
Chairman
Biotech and Pharma Drug Development Strategy
Christophe Berthoux has been serving as the Chairman of Image Analysis Group (IAG) since September 1, 2018, bringing over 20 years of leadership experience in the clinical research industry. Prior to IAG, he held key positions including CEO of Synexus Limited, Chief Executive of Citoxlab, and Chief Commercial Officer at Charles River Laboratories International Inc. Dr. Berthoux, who holds a doctorate in veterinary medicine and an MBA from Purdue University, was appointed to develop IAG's growth and people strategies, leveraging his extensive expertise in international clinical trials. His leadership at IAG focuses on driving successful growth and international expansion for the company, while he also serves as an Operating Partner at ArchiMed and CEO of NAMSA.
IAG, Image Analysis Group
Our next-gen platform, R&D and service divisions together with funding mechanisms holistically address the broader issues experienced by biopharma with active and often complex clinical trial pipelines by providing an integrated approach to clinical development and strategic planning.
Image Management Platform
Real-time information, patented data analysis methodologies, flexible reporting options for all stakeholders ensure transparency of trial process and the use of the latest scientific innovation in proving efficacy of your novel treatments.
Careers
In addition to specific listed roles, we are always looking for biotech and pharma experts and enthusiasts with entrepreneurial mindset, can-do attitude and solid scientific background.